| Immunotherapy in COVID-19: why, who, and when? #MMPMID34015326Sinha P; Calfee CSLancet Respir Med 2021[Jun]; 9 (6): 549-551 PMID34015326show ga
ä|*COVID-19[MESH]|Humans[MESH]|Immunologic Factors[MESH]|Immunotherapy[MESH]|Receptors, Interleukin-6[MESH]
DeepDyve Pubget Overpricing |
|